本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Tyra Biosciences, Inc.

10.37
-0.5600-5.12%
盘后10.370.00000.00%16:10 EDT
成交量:28.37万
成交额:298.03万
市值:5.51亿
市盈率:-6.34
高:10.82
开:10.78
低:10.33
收:10.93
数据加载中...
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/09/18

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/06/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/31

重要事件披露

Form 8-K - Current report
2024/05/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/09

重要事件披露

Form 8-K - Current report
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/19

SEC问询函

Form CORRESP - Correspondence
2024/03/19

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/19

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/19

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/08

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/02/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities